DS
TFFP

David Shaw’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

David Shaw’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-564
Closed -$136K – 5298
2021
Q2 		$136K Buy
+564
New +$155K ﹤0.01% 4513

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

David Shaw's TFFP Position: Q3 2021 in Review

David Shaw sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2021, closing a stake of 564 shares — an estimated $136K sold.

David Shaw first reported a position in TFFP in Q2 2021 and held it in 1 quarter. The position peaked at $136K in Q2 2021. 54 funds tracked by Wall St. Rank hold TFFP as of Q3 2021.

  • David Shaw reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • David Shaw sold 564 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $136K.
  • David Shaw first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • David Shaw's TFF Pharmaceuticals, Inc. Common Stock position peaked at $136K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.